Characterization of the Intraclonal Complexity of Chronic Lymphocytic Leukemia B Cells: Potential Influences of B-Cell Receptor Crosstalk with Other Stimuli.
Toll-like receptor 9
chronic lymphocytic leukemia
immunoglobulin
intraclonal diversity
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Sep 2023
25 Sep 2023
Historique:
received:
16
08
2023
revised:
15
09
2023
accepted:
18
09
2023
medline:
14
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Chronic lymphocytic leukemia (CLL) clones contain subpopulations differing in time since the last cell division ("age"): recently born, proliferative (PF; CXCR4
Identifiants
pubmed: 37835400
pii: cancers15194706
doi: 10.3390/cancers15194706
pmc: PMC10571896
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Union Horizon 2020 research and innovation program under the Marie Sklodowska-Curie
ID : 101023721
Organisme : The Karches Family Foundation
ID : philanthropic contributions
Organisme : The Nash Family Foundation
ID : philanthropic contributions
Organisme : The Muriel Fusfeld Foundation
ID : philanthropic contributions
Organisme : The Jean Walton Fund for Leukemia, Lymphoma, and Myeloma Research
ID : philanthropic contributions
Références
J Immunol. 2001 Feb 1;166(3):1507-16
pubmed: 11160190
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):114-7
pubmed: 1370346
Front Immunol. 2021 Jul 01;12:686768
pubmed: 34276674
Elife. 2014 Jun 24;3:e02069
pubmed: 24963139
Blood. 2013 Oct 24;122(17):3010-9
pubmed: 24014238
Cancer J. 2021 Jul-Aug 01;27(4):306-313
pubmed: 34398557
Elife. 2018 Mar 09;7:
pubmed: 29521626
Blood. 2014 Mar 13;123(11):1709-19
pubmed: 24464016
Semin Immunol. 1998 Aug;10(4):267-77
pubmed: 9695183
Blood Cancer J. 2021 Feb 18;11(2):39
pubmed: 33602908
Leukemia. 2017 Jun;31(6):1348-1354
pubmed: 28115735
Leukemia. 2017 Jun;31(6):1340-1347
pubmed: 28074063
Nat Commun. 2012 Apr 03;3:767
pubmed: 22473011
Cell Death Differ. 2021 May;28(5):1658-1668
pubmed: 33495554
Trends Immunol. 2016 May;37(5):310-320
pubmed: 27052149
Int J Mol Sci. 2022 Nov 17;23(22):
pubmed: 36430731
J Clin Invest. 2022 Jan 18;132(2):
pubmed: 34813501
FEBS Lett. 2017 Jan;591(2):282-294
pubmed: 28027393
Sci Signal. 2015 Sep 15;8(394):ra93
pubmed: 26373673
Blood. 2022 Dec 1;140(22):2335-2347
pubmed: 36084319
Nat Rev Cancer. 2018 Mar;18(3):148-167
pubmed: 29348577
J Immunol. 2016 Sep 15;197(6):2522-31
pubmed: 27534555
Methods Mol Biol. 2019;1881:129-151
pubmed: 30350203
Nat Immunol. 2015 May;16(5):534-43
pubmed: 25848865
Trends Immunol. 2013 Dec;34(12):592-601
pubmed: 23928062
Leukemia. 2023 Jun;37(6):1268-1276
pubmed: 37100883
Ann Hematol. 2016 Dec;95(12):1979-1988
pubmed: 27542958
J Exp Med. 2005 Jul 18;202(2):321-31
pubmed: 16027240
Lancet. 2018 Apr 14;391(10129):1524-1537
pubmed: 29477250
Cancer Immunol Immunother. 2022 Apr;71(4):979-987
pubmed: 34467417
J Exp Med. 2005 Nov 7;202(9):1171-7
pubmed: 16260486
JCI Insight. 2017 Jan 26;2(2):e89904
pubmed: 28138560
Blood. 2021 Jun 3;137(22):3064-3078
pubmed: 33512408
Mol Med. 2011;17(11-12):1374-82
pubmed: 21968788
J Exp Med. 1989 Jan 1;169(1):255-68
pubmed: 2462608
Nat Rev Cancer. 2014 Apr;14(4):219-32
pubmed: 24658273
J Allergy Clin Immunol. 2016 Mar;137(3):889-98.e6
pubmed: 26478008
Blood Adv. 2023 Jan 10;7(1):145-158
pubmed: 35358998
Cell Death Dis. 2018 Jan 24;9(2):86
pubmed: 29367645
J Immunol. 2015 Aug 1;195(3):901-23
pubmed: 26136429
Blood. 2009 Nov 26;114(23):4832-42
pubmed: 19789386
Nat Immunol. 2008 Jan;9(1):63-72
pubmed: 18059271
Front Oncol. 2021 Dec 16;11:790004
pubmed: 34976831
PLoS One. 2013 Aug 14;8(8):e74103
pubmed: 23967355
Front Biosci (Landmark Ed). 2013 Jan 01;18(1):371-86
pubmed: 23276930